S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Apricus CEO to Discuss Company's Drug Portfolio, Including Its Topical Cream for Erectile Dysfunction, Vitaros(R), LIVE on iHeart (Clear Channel) Business Talk Radio DFW 1190AM on Sept. 25, 2014|
|Apricus Biosciences Announces Third Quarter 2014 Financial Results and Provides Corporate Update|
|Apricus Biosciences Provides Corporate Update and Second Quarter 2014 Financial Results|
|Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Belgium by Sandoz|
|Apricus Biosciences Announces the Launch of Its Topical Treatment for Erectile Dysfunction Vitaros(R) in Sweden by Sandoz|
|Apricus Biosciences Announces the Launch of Its Topical Treatment for Erectile Dysfunction Vitaros(R) in Germany by Hexal|
|Apricus Biosciences Announces Multi-Year Partnership With the Scleroderma Research Foundation|
|Apricus Biosciences Announces Notice of Allowance of U.S. Patent Application for RayVa(TM)|
|Apricus Biosciences Enters Into Common Stock Purchase Agreement With Aspire Capital|
|Apricus Biosciences Announces Appointment of Sandford D. Smith to Board of Directors|
Click above to view more mutual fund data and stats for apri - Apricus Biosciences Inc.